MedPath

National Cancer Center Korea

National Cancer Center Korea logo
🇰🇷South Korea
Ownership
Subsidiary
Established
1989-01-01
Employees
-
Market Cap
-
Website
http://www.ncc.re.kr

Safety and Efficacy of One Dose Prophylactic Antibiotic in Laparoscopic Colorectal Surgery

Phase 2
Completed
Conditions
Colorectal Surgery
Interventions
First Posted Date
2010-10-14
Last Posted Date
2011-12-13
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
312
Registration Number
NCT01220661
Locations
🇰🇷

National Cancer Center Hospital, Goyang, Gyeonggi-do, Korea, Republic of

Study of External Beam Radiotherapy to Thyroid Carcinoma

Phase 2
Completed
Conditions
Thyroid Cancer
Interventions
Radiation: External Beam Radiotherapy
First Posted Date
2010-08-02
Last Posted Date
2015-10-07
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
62
Registration Number
NCT01173289
Locations
🇰🇷

National Cancer Center, Korea, Goyang-si, Gyeonggi-do, Korea, Republic of

Genexol-PM Versus Paclitaxel in Anthracycline-pretreated Metastatic Breast Cancer Patients

Phase 2
Withdrawn
Conditions
Breast Cancer
Interventions
Drug: Genexol-PM
First Posted Date
2010-07-26
Last Posted Date
2012-01-04
Lead Sponsor
National Cancer Center, Korea
Registration Number
NCT01169870

Clinical Trial for Laparoscopic D2 Gastrectomy

Phase 2
Completed
Conditions
Gastric Cancer
Interventions
Procedure: Laparoscopic D2 distal gastrectomy
First Posted Date
2010-07-16
Last Posted Date
2010-07-19
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
64
Registration Number
NCT01163812
Locations
🇰🇷

National Cancer Center, Goyang, Gyeonggido, Korea, Republic of

Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy

Phase 2
Terminated
Conditions
Small Cell Lung Cancer
Interventions
First Posted Date
2010-07-09
Last Posted Date
2015-11-11
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
13
Registration Number
NCT01159327
Locations
🇰🇷

National Cancer Center, Korea, Goyang-si, Gyeonggi-do, Korea, Republic of

BIBW 2992 Plus Simvastatin vs. BIBW 2992 in Previously Treated Patients With Advanced Non-adenocarcinomatous NSCLC

Phase 2
Completed
Conditions
Non-small Cell Lung Cancer
Interventions
First Posted Date
2010-07-05
Last Posted Date
2022-04-06
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
68
Registration Number
NCT01156545
Locations
🇰🇷

National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of

Short-course Preoperative Chemoradiotherapy Followed by Delayed Operation for Locally Advanced Rectal Cancer

Phase 2
Completed
Conditions
Rectal Cancer
First Posted Date
2010-05-25
Last Posted Date
2012-04-27
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
73
Registration Number
NCT01129700
Locations
🇰🇷

National Cancer Center Korea, Goyang-si, Gyeonggi-do, Korea, Republic of

Intraoperative Hyperthermic Intraperitoneal Chemotherapy With Ovarian Cancer

Phase 2
Completed
Conditions
Epithelial Ovarian Cancer
Interventions
Procedure: Hyperthermic Intraperitoneal Chemotherapy
First Posted Date
2010-03-24
Last Posted Date
2020-02-17
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
184
Registration Number
NCT01091636
Locations
🇰🇷

National Cancer Center, Goyang, Gyeonggi, Korea, Republic of

Feasibility Study of Laparoscopy-assisted D2 Distal Gastrectomy to Treat Advanced Gastric Cancer

Phase 2
Conditions
Gastric Cancer
Interventions
Procedure: open distal gastrectomy
Procedure: laparoscopy assisted distal gastrectomy
First Posted Date
2010-03-17
Last Posted Date
2015-10-07
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
204
Registration Number
NCT01088204
Locations
🇰🇷

Chonnam National University Hwasun Hospital, Hwasun, Chollanam Do, Korea, Republic of

🇰🇷

Gyengsang National University Hospital, Jinju, Gyeongsangnam -Do, Korea, Republic of

🇰🇷

Kyungpook national university hospital, Dae Gu, Korea, Republic of

and more 4 locations

A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection

Phase 2
Completed
Conditions
Cholangiocarcinoma
Interventions
First Posted Date
2010-01-06
Last Posted Date
2018-01-03
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
72
Registration Number
NCT01043172
Locations
🇰🇷

National Cancer Center, Goyang, Gyeonggi, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath